BioCentury
ARTICLE | Financial News

Affymetrix falls on preliminary 1Q13 results

April 10, 2013 1:31 AM UTC

Affymetrix Inc. (NASDAQ:AFFX) slipped $0.64 (14%) to $4.02 on Tuesday after saying it expects 1Q13 revenue to be about $78 million, below the Street's estimate of $83.3 million. The microarray company...